SCHEMBL24676095

SCHEMBL24676095

c1ccc2c(c1)oc1ccc3c4ccccc4n(-c4ccc(-n5c6ccccc6c6ccc7oc8ccccc8c7c65)cc4)c3c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
ATM Q13315 1/20 0.44
ALDH1A1 P00352 7/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
HPGD P15428 4/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HSD17B10 Q99714 3/20 0.37
POLB P06746 3/20 0.37
MAPK1 P28482 1/20 0.37
DUSP3 P51452 1/20 0.37
PTPN5 P54829 1/20 0.37
PTPN11 Q06124 1/20 0.37
MAPT P10636 3/20 0.36
MAOA P21397 2/20 0.36
GLA P06280 1/20 0.36
CYP3A4 P08684 1/20 0.36
PGAM1 P18669 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17246177 0.98 KDM4E (0.47) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24676321 0.95 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24676179 0.95 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL17246088 0.95 KDM4E (0.52) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24675414 0.94 KDM4E (0.43) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24174744 0.94 KDM4E (0.43) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL19038266 0.93 L3MBTL1 (0.39) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL18435995 0.93 KDM4E (0.39) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL15451818 0.93 L3MBTL1 (0.47) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL18620216 0.92 KDM4E (0.49) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230033529-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-02 US disclosed
US-20220238815-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2022-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230033529-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, RAP1A KDM4E 3096/4885L3MBTL1 173/4885ATM 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.